Rheumatoid arthritis: basic pathophysiology and role of chitosan nanoparticles in therapy-Reference-Cited by-同舟云学术

Rheumatoid arthritis: basic pathophysiology and role of chitosan nanoparticles in therapy

Published:2020 Issue: Volume: Page:481-507
ISSN:
Container-title:Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents
language:
Short-container-title:

Author:

Kumar Vijay,Kanwar Jagat R.,Verma Anita Kamra

Publisher

Elsevier

Reference139 articles.

1. Biologics in development for rheumatoid arthritis: relevance to osteoarthritis B;Abramson;Adv. Drug Deliv. Rev.,2006

2. Versatility of chitosan: a short review;Agarwal;J. Pharm. Res.,2015

3. Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory Th17 cells and therapeutic implications;Alunno;Mediators Inflam.,2015

4. Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA);Ando;J. Bone Miner. Metab.,2006

5. One year in review 2017: pathogenesis of rheumatoid arthritis;Angelotti;Clin. Exp. Rheumatol.,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formulation, Characterization, and Optimization of Transethosomes for Enhanced Transdermal Delivery of Methotrexate;Journal of Pharmaceutical Innovation;2023-12

2. Nanoparticulate drug delivery systems for the treatment of rheumatoid arthritis: A comprehensive review;Journal of Drug Delivery Science and Technology;2023-03

3. Role of IL-33 and IL-35 in the Pathogenesis of Rheumatoid Arthritis;Experimental and Applied Biomedical Research (EABR);2023-01-27

4. Folic acid-decorated PEGylated magnetite nanoparticles as efficient drug carriers to tumor cells overexpressing folic acid receptor;International Journal of Pharmaceutics;2022-09

5. The Impact of Curcumin on the Inflammatory Profile of SW982 Cells in a Rheumatoid Arthritis Model;Journal of Immunology Research;2022-04-12